Skip to main content
. 2023 Feb 20;38(1):2171026. doi: 10.1080/14756366.2023.2171026

Table 3.

Effect of terpenoids derivatives on the various pathological pathways involve in AD.

Compound No. Classification The major targets Activity (µM) References
36–44 Triptolide derivatives Protect nerve cells from Aβ1-42 damage
Inhibits LPS induce TNF
_ 51
45/46 Andrographolide derivatives Inhibits LPS induced NO production, iNOS expression and proinflammatory cytokine TNF- α and IL-6
Protect neurons from microglia mediated neurotoxicity
Promotes NGF induced axon growth in PC12 cells
_ 52
47-49 β-Secretase inhibitors
AChE inhibitory activity
_ 53
50 Glycyrrhetinic acid derivatives AChE inhibitory activity IC50 (hAChE) = 3.43 54
51 IC50 (hAChE) = 5.39
52 IC50 (hAChE) = 6.27
53 IC50 (hAChE) = 8.68
54 BChE inhibitory activity IC50 (hBChE) = 5.43 55
55 IC50 (hBChE) = 9.81
56 Safranal derivatives MAO-A inhibitory activity
MAO-B inhibitory activity
IC50 (hMAO-A) = 9.93
IC50 (hMAO-B) = 0.0091
56